Stifel Reiterates Buy Rating on Crinetics (CRNX)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. IVBIY

Go back to Stifel Reiterates Buy Rating on Crinetics (CRNX)

Crinetics (CRNX) PT Raised to $80 at Morgan Stanley

January 5, 2026 1:44 PM EST

Morgan Stanley analyst Jeffrey Hung raised the price target on Crinetics (NASDAQ: CRNX) to $80.00 (from $77.00) while maintaining a Overweight rating.

The analyst comments "We see atumelnant data continuing to demonstrate potential best-in-class efficacy, with no hepatic transaminase AEs. Nearterm, we expect investor... More